Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published online before print December 7, 2009, 10.1097/PSY.0b013e3181c64fc0
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer, T.
Right arrow Articles by Herrmann-Lingen, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer, T.
Right arrow Articles by Herrmann-Lingen, C.
Related Collections
Right arrow Anxiety
Right arrow Coronary Artery Disease
Psychosomatic Medicine 72:9-15 (2010)
© 2010 American Psychosomatic Society


ORIGINAL ARTICLES

Role of Cardiac Disease Severity in the Predictive Value of Anxiety for All-Cause Mortality

Thomas Meyer, PhD, MD, Ullrich Buss, MD and Christoph Herrmann-Lingen, MD

From the Department of Cardiology (T.M.), University of Marburg, Marburg, Germany, and Department of Psychosomatic Medicine and Psychotherapy (U.B., C.H.-L.), University of Göttingen, Göttingen, Germany.

Address correspondence and reprint requests to Christoph Herrmann-Lingen, Psychosomatic Medicine and Psychotherapy, von-Siebold-Str. 5, D-37075 Göttingen, Germany. E-mail: cherrma{at}gwdg.de

Objective: To identify moderators that influence the relationship of anxiety and long-term prognosis in patients with coronary heart disease (CHD). It has been an ongoing source of controversy what the long-term effects of anxiety are on mortality in patients with CHD, suggesting heterogeneity in prognostic parameters.

Methods: The prognostic role of anxiety was examined in a large sample of patients (n = 4864), who completed the Hospital Anxiety and Depression Scale (HADS) before routine exercise testing. At 5-year follow-up, survival data were obtained and mortality was assessed by means of Cox proportional hazard models.

Results: In the whole sample, higher anxiety scores were associated with reduced mortality (adjusted hazard ratio [HR] = 0.77; 95% confidence interval (CI) = 0.67–0.88; p < .001). Similar findings were obtained in the subgroup of patients without clinical evidence of CHD (n = 2514; HR = 0.74; 95% CI = 0.59–0.93; p = .01). In patients with CHD but without a history of myocardial infarction (MI), anxiety remained a significant predictor of better survival (HR = 0.70; 95% CI = 0.51–0.97; p = .031). In post-MI patients, no beneficial effect of anxiety was observed. In the subgroup of post-MI patients with reduced ejection fraction, anxiety was associated with increased mortality (n = 536; HR = 1.32; CI = 1.07–1.65; p = .011).

Conclusion: Anxiety exhibits opposite effects on survival in patients with stable cardiac conditions versus post-MI patients with reduced systolic left ventricular (LV) function. We found that a noninvasive physical risk index and the degree of LV dysfunction seem to modulate the prognostic significance of anxiety. These data suggest that the combined screening for anxiety symptoms and LV dysfunction may improve risk stratification in patients with CHD.

Key Words: anxiety • coronary heart disease • myocardial infarction • prognosis • risk stratification

Abbreviations: CHD = coronary heart disease; HADS = Hospital Anxiety and Depression Scale; LV = left ventricle; MI = myocardial infarction.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2010 by the American Psychosomatic Society